Summary: The Centers for Medicare & Medicaid Services modified its Blood Counts coverage policy, effective May 15, 2026. Here's what billing teams need to know before claims start hitting your denial queue.

CMS blood counts coverage policy updates don't always get the attention they deserve—until your denial rate spikes. This modification affects how Medicare reimburses for complete blood count (CBC) and related hematology tests ordered in clinical settings. The policy does not list specific CPT or HCPCS codes in the available data, so your billing team needs to pull the full policy document to confirm which codes fall under the updated criteria before the May 15, 2026 effective date.


Quick-Reference Table

Field Detail
Payer CMS
Policy Blood Counts
Policy Code N/A
Change Type Modified
Effective Date 2026-05-15
Impact Level Medium
Specialties Affected Internal medicine, primary care, oncology, hematology, nephrology, hospital outpatient departments
Key Action Review your lab billing guidelines for CBC and differential panels against updated medical necessity criteria before May 15, 2026

CMS Blood Counts Coverage Criteria and Medical Necessity Requirements 2026

The CMS blood counts coverage policy governs when Medicare will pay for complete blood counts, automated differentials, and related hematology panels. Medical necessity is the central issue here. Medicare does not reimburse for routine or screening lab work without a clinical indication tied to a specific diagnosis or symptom.

Blood count testing sits at the intersection of high volume and close scrutiny. CMS and Medicare Administrative Contractors (MACs) flag lab claims frequently because ordering patterns often don't match documentation. If the ordering provider's notes don't support the diagnosis on the claim, you're looking at a claim denial—regardless of how routine the test feels in clinical practice.

The modification effective May 15, 2026 signals that CMS reviewed the existing criteria and made adjustments. Because the full policy detail is not available in the current dataset, the exact scope of those changes isn't confirmed here. Pull the current policy directly from your MAC's local coverage determination (LCD) database and compare it against the prior version. That comparison will tell you whether the criteria tightened, loosened, or shifted to address specific clinical scenarios.

Prior authorization is not typically required for standard blood count panels under Medicare Part B. But that doesn't mean you can skip documentation. Medical necessity must be established in the ordering provider's clinical record. The diagnosis code on the claim has to connect logically to the test ordered—CMS auditors look for that connection on every claim.

Reimbursement for blood counts under Medicare follows the Clinical Laboratory Fee Schedule (CLFS). CMS updates CLFS rates annually, and this policy modification may interact with how certain codes are grouped or covered independent of rate changes. Check both the coverage policy and the 2026 CLFS together—they're separate documents, but they affect the same claims.


CMS Blood Counts Exclusions and Non-Covered Indications

The policy data available does not specify exclusions. However, CMS consistently excludes blood count testing in two scenarios: when ordered without a documented clinical indication, and when ordered as part of a routine screening protocol not tied to an active diagnosis or symptom.

Standalone screening CBCs—ordered annually "just to check"—are not covered under Medicare Part B unless the beneficiary qualifies under a specific preventive benefit. Most don't. If your ordering providers document "routine screening" without a supporting ICD-10 code that meets medical necessity, expect a denial.

Repeated testing within short intervals also draws scrutiny. If a patient has a CBC drawn three times in a single week, your documentation needs to explain why each draw was medically necessary. Oncology and nephrology practices often have legitimate reasons for frequent monitoring—but the documentation has to support it, and the claim has to reflect it.


Coverage Indications at a Glance

Because the full policy document is not available in the current dataset, a complete indication-by-indication table cannot be confirmed here. The table below reflects what CMS has historically covered and excluded for blood count testing under Medicare. Verify each row against the updated policy before May 15, 2026.

Indication Status Relevant Codes Notes
CBC with differential for documented anemia workup Covered Confirm with MAC LCD Medical necessity documentation required
CBC monitoring during chemotherapy Covered Confirm with MAC LCD Frequency limits may apply; document clinical rationale
CBC for evaluation of infection or fever of unknown origin Covered Confirm with MAC LCD Diagnosis must be documented in ordering record
+ 4 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

This policy is now in effect (since 2026-05-15). Verify your claims match the updated criteria above.

CMS Blood Counts Billing Guidelines and Action Items 2026

#Action Item
1

Pull the updated policy before May 15, 2026. Go directly to the CMS website and your MAC's LCD portal. The available data here does not include code-level specifics. You need the full policy document to confirm which CPT codes are in scope and whether the medical necessity criteria changed in ways that affect your patient population.

2

Audit your ICD-10 pairing practices now. Blood count billing denials almost always trace back to mismatched diagnosis codes. Run a report on your last 90 days of blood count claims. Check whether the ICD-10 codes on those claims match the clinical documentation. Fix any patterns you find before the effective date.

3

Brief your ordering providers on documentation requirements. The billing team can't fix a claim denial caused by incomplete physician notes. If the ordering provider doesn't document the indication for the test, no amount of clean billing will get that claim paid. Schedule a short touchpoint with your clinical staff before May 15, 2026.

+ 4 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
+ 1 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CPT, HCPCS, and ICD-10 Codes for Blood Counts Under the CMS Blood Counts Coverage Policy

The available policy data does not include specific CPT, HCPCS, or ICD-10 codes. Do not rely on this post for code-level billing decisions.

This is the part where a lot of billing teams get burned. A policy summary exists, but the code data isn't attached to it yet—and someone builds a workaround based on assumptions. Don't do that here.

How to Get the Real Code List

Go to the CMS coverage database and your MAC's LCD portal. Search for "blood counts" or the relevant LCD number for your jurisdiction. The LCD will list every covered CPT code, the covered ICD-10 codes that establish medical necessity, and any frequency or billing limitations.

Common CPT codes associated with blood count testing in Medicare billing include codes in the 85000–85999 range of the CPT code set. That range covers hematology and coagulation. But confirming which specific codes fall under this CMS policy modification requires the full policy document—not an assumption based on category.

Why This Gap Matters

When a policy is modified but the code list isn't published in the summary, it often means one of two things: the code list didn't change (and the modification affects criteria or documentation requirements), or the code list update is pending MAC-level action. Either way, your billing team should verify before May 15, 2026—not after your first denial.

If you want to flag this for follow-up, the source URL for this policy is: https://app.payerpolicy.org/p/cms/61-v1


Get the Full Picture

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee